Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved save search
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Published: 2021-03-05 (Crawled : 15:00) - biospace.com/
EYES | $4.14 -0.24% 3.14%
|
Health Technology
|
| O: 60.14%
H: 331.88%
C: 152.84%
fda fda approval retina approval
Trevena Announces Approval of OLINVYK in China
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
TRVN | $0.362 -2.22% -2.27% 140K
|
Health Technology
|
| O: 23.32%
H: 322.19%
C: 300.31%
approval olinvyk china
Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate
Published: 2021-05-24 (Crawled : 14:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -3.69%
H: 247.56%
C: 78.57%
fda biopharma fda approval drug approval application
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
PBLA | News | $0.4748 -6.31% 20K
|
Professional, Scientific, and T...
|
| O: 29.1%
H: 177.92%
C: 71.16%
approval therapeutics
PROOF Acquisition Corp I Stockholders Approve Previously … – Marketscreener.com
Published: 2023-11-29 (Crawled : 12:00) - spacfeed.com
PACI M | $3.77 298.67% 330
|
n/a
|
| O: 8.22%
H: 150.9%
C: 129.46%
acquisition
Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -50.0%
H: 150.0%
C: 125.0%
approval canada
U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition
Published: 2021-11-18 (Crawled : 12:13) - globenewswire.com
LGVN 4 d | $1.79 -4.28% -4.47% 270K
|
|
| O: 27.4%
H: 139.24%
C: 84.68%
disease food rare pediatric disease designation heart drug lomecel-b designation rare
Earth Science Tech, Inc., Appoints New CFO and Shares that RxCompoundStore.com, LLC. has Received Approval to Ship into Additional States
Published: 2023-07-17 (Crawled : 20:00) - globenewswire.com
ETST P | $0.065 -67.14% 110K
|
Manufacturing
|
| O: -9.09%
H: 130.0%
C: 130.0%
approval
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
AIMD | $1.01 -0.98% 27K
|
Manufacturing
|
| O: -53.53%
H: 121.08%
C: 30.32%
covid-19 approval
VinFast partner’s shareholders approve merger, setting stage for $23B deal – WRAL TechWire
Published: 2023-08-10 (Crawled : 17:00) - spacfeed.com
BSAQ | News | $10.2 2.45% 380
|
|
| O: 1.96%
H: 109.17%
C: 69.72%
APMI | $10.32 0.1% 2.9K
|
|
| O: 0.15%
H: 0.0%
C: -0.19%
deal
AVEO Oncology Announces U.S. FDA Approval of FOTIVDA® (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma
Published: 2021-03-10 (Crawled : 21:01) - biospace.com/
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.73%
H: 86.98%
C: 85.89%
treatment fda renal fda approval approval cell carcinoma
1847 Holdings Announces NYSE American Listing Approval
Published: 2022-04-27 (Crawled : 17:00) - globenewswire.com
EFSH 4 | $2.79 17.92% 0.0% 460K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 83.67%
C: 38.78%
approval
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 26.26%
H: 73.2%
C: 18.87%
health cancer care for commercial
Sidus Space Secures NOAA Approval to Provide Imaging Services to Government and Commercial Customers
Published: 2024-01-03 (Crawled : 13:30) - sidusspace.com
SIDU | $3.44 0.88% 0.87% 24K
|
|
| O: 11.76%
H: 73.04%
C: 49.42%
services approval space commercial imaging
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
Published: 2023-03-14 (Crawled : 21:00) - prnewswire.com
SMIH | $9.0998 48.36% 0
|
|
| O: 5.77%
H: 67.64%
C: 18.18%
biopharma business approval
Canoo’s Oklahoma City Manufacturing Facility Approved as Foreign Trade Zone
Published: 2024-03-18 (Crawled : 10:00) - globenewswire.com
GOEV 4 | $3.16 -7.06% -7.59% 3.5M
|
|
| O: 20.62%
H: 65.81%
C: 23.93%
approved city zone
Extreme Biodiesel, Inc. The Company’s Board of Directors has approved the motion to immediately terminate the Reg A
Published: 2022-01-19 (Crawled : 17:00) - globenewswire.com
XTRM | $0.0001 0.0% 11M
|
Manufacturing
|
| O: -3.33%
H: 62.07%
C: 31.03%
media
Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval
Published: 2023-08-29 (Crawled : 09:00) - globenewswire.com
NUGL | $0.005 -69.01% 3.2K
|
Administrative and Support and ...
|
| O: 64.84%
H: 62.0%
C: -35.33%
approval wellness acquire
Energous Corporation Announces First Customer Product Approval from FCC
Published: 2018-12-27 (Crawled : 14:59) - globenewswire.com
WATT | $1.345 -0.37% -0.37% 23K
|
Electronic Technology
|
| O: 31.66%
H: 59.04%
C: 16.75%
approval
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
Published: 2021-06-07 (Crawled : 18:00) - globenewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 3.22%
H: 58.64%
C: 34.03%
disease alzheimer treatment fda approval alzheimer’s alzheimer's disease alzheimer's
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.